Recent evidence suggests that monoamine oxidase inhibitors have the greatest efficacy in the treatment of

Question

Quizplus · Accepted Answer

Recent studies have shown that monoamine oxidase inhibitors (MAOIs) are particularly effective in treating atypical depression. Atypical depression is a subtype of major depressive disorder characterized by symptoms such as hypersomnia, weight gain, and mood reactivity. MAOIs are thought to work by increasing the levels of monoamine neurotransmitters like serotonin, norepinephrine, and dopamine in the brain, which can improve mood and alleviate symptoms of depression. While MAOIs may also be used to treat other conditions like bipolar depression, their efficacy in atypical depression is particularly notable.

Recent Evidence Suggests That Monoamine Oxidase Inhibitors Have the Greatest